Advanced Search Results For "AND COVID-19 Subject OR COVID-19 pandemic Subject OR SARS-CoV-2 Subject OR SARS-CoV-2 Delta variant Subject OR SARS-CoV-2 Omicron variant Subject "
Your filters
Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2.
Publication Type: Academic Journal
Source(s): Frontiers in Pharmacology; 7/4/2022, Vol. 13, p1-19, 19p
Abstract: Copyright of Frontiers in Pharmacology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, d...
Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development
Publication Type: Academic Journal
Source(s): Frontiers in Pharmacology, Vol 14 (2023)
Abstract: Introduction: Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has had a disastrous effect worldwide during the previous three years due to widespread infections with SARS-CoV-2 and its emerging variations. More than 674 million confirmed cas...
Thymoquinone's Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge.
Publication Type: Academic Journal
Source(s): Frontiers in Pharmacology; 4/7/2022, Vol. 13, p1-10, 10p
Abstract: Copyright of Frontiers in Pharmacology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, d...
Nirmatrelvir/ritonavir for patients with SARS-CoV-2 infection and impaired kidney function during the Omicron surge.
Publication Type: Academic Journal
Source(s): Frontiers in Pharmacology; 3/22/2023, Vol. 14, p01-11, 11p
Abstract: Copyright of Frontiers in Pharmacology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, d...
Jin-Zhen oral liquid for pediatric coronavirus disease (COVID-19): A randomly controlled, open-label, and non-inferiority trial at multiple clinical centers.
Publication Type: Academic Journal
Source(s): Frontiers in Pharmacology; 2/27/2023, Vol. 14, p1-11, 11p
Abstract: Copyright of Frontiers in Pharmacology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, d...
Randomized, placebo-controlled, single-blind phase 1 studies of the safety, tolerability, and pharmacokinetics of BRII-196 and BRII-198, SARS-CoV-2 spike-targeting monoclonal antibodies with an extended half-life in healthy adults.
Publication Type: Academic Journal
Source(s): Frontiers in Pharmacology; 9/6/2022, Vol. 13, p1-9, 9p
Abstract: Copyright of Frontiers in Pharmacology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, d...
A retrospective study of Pupingqinghua prescription versus Lianhuaqingwen in Chinese participants infected with SARS-CoV-2 Omicron variants.
Publication Type: Academic Journal
Source(s): Frontiers in Pharmacology; 10/7/2022, Vol. 13, p01-12, 12p
Abstract: Copyright of Frontiers in Pharmacology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, d...
Real-world effectiveness of Yindan Jiedu granules-based treatment on patients infected with the SARS-CoV-2 Omicron variants BA.2 combined with high-risk factors: A cohort study.
Publication Type: Academic Journal
Source(s): Frontiers in Pharmacology; 8/16/2022, Vol. 13, p1-12, 12p
Abstract: Copyright of Frontiers in Pharmacology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, d...
Antiviral Efficacy and Safety of Molnupiravir Against Omicron Variant Infection: A Randomized Controlled Clinical Trial.
Publication Type: Academic Journal
Source(s): Frontiers in Pharmacology; 6/15/2022, Vol. 13, p1-6, 6p
Abstract: Copyright of Frontiers in Pharmacology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, d...
Trends and characteristics of COVID-19 and cardiovascular disease related studies.
Publication Type: Academic Journal
Source(s): Frontiers in Pharmacology; 2023, p1-10, 10p
Abstract: Copyright of Frontiers in Pharmacology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, d...